SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3634-3641

  Cheng, Chien Jui ^a,b   Lin, Yuh Charn ^d   Tsai, Ming Tzu ^d   Chen, Ching Shyang ^c   Hsieh, Mao Chih ^e   Chen, Chi Long ^a,c   Yang, Ruey Bing ^d,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b School of Medicine   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEIN ANTIBODY; PROTEIN DERIVATIVE; SIGNAL PEPTIDE CUB EPIDERMAL GROWTH FACTOR LIKE DOMAIN CONTAINING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 65949107334     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3615     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108. (Pubitemid 40372904)
2. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J. Clin. Oncol 2003; 21: 3357-65. (Pubitemid 46606270)
3. Andre F, Pusztai L. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy. Nat Clin. Pract Oncol 2006; 3: 621-32. (Pubitemid 44669717)
4. Brennan DJ, Gallagher WM. Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution.' Breast Cancer Res 2008; 10: 102.
5. Perou CM, Sorlie T, Eisen MB. et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
6. van de Vijver MJ, He YD, van't Veer LJ. et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J. Med 2002; 347: 1999-2009. (Pubitemid 35461656)
7. van 't Veer LJ, Dai H, van de Vijver MJ. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6. (Pubitemid 34130608)
8. Paik S, Shak S, Tang G. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J. Med 2004; 351: 2817-26. (Pubitemid 40051905)
9. Paik S, Tang G, Shak S. et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J. Clin. Oncol 2006; 24: 3726-34. (Pubitemid 46622311)
10. Wang Y, Klijn JG, Zhang Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005 ;365: 671-9. (Pubitemid 40260888)
11. Fan C, Oh DS, Wessels L. et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J. Med 2006; 355: 560-9. (Pubitemid 44200649)
12. Yang RB, Ng CK, Wasserman SM. et al. Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J. Biol. Chem 2002; 277: 46364-73. (Pubitemid 35417631)
13. Grimmond S, Larder R, Van Hateren N. et al. Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). Genomics 2000; 70: 74-81.
14. Grimmond S, Larder R, Van Hateren N. et al. Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development Mech Dev 2001; 102: 209-11. (Pubitemid 32273599)
15. Tu CF, Su YH, Huang YN. et al. Localization and characterization of a novel protein SCUBE1 in human platelets. Cardiovasc Res 2006; 71: 486-95. (Pubitemid 44107858)
16. Tu CF, Yan YT, Wu SY. et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J. Biol. Chem 2008; 283: 12478-88.
17. Wu BT, Su YH, Tsai MT, Wasserman SM, Topper JN, Yang RB. A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones. J. Biol. Chem 2004; 279: 37485-90. (Pubitemid 39195459)
18. Dai DF, Thajeb P, Tu CF. et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J. Am Coll Cardiol 2008; 51: 2173-80.
19. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J. Clin. Oncol 1999; 17: 1474-81. (Pubitemid 29220854)
20. Carlson RW, Moench SJ, Hammond ME. et al. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J. Natl Compr Cane Netw 2006; 4 Suppl 3: S1-22; quiz S3-4.1 (Pubitemid 44258754)
21. AJCC Cancer Staging Manual. In: Greene FL, Page DL, Fleming ID. et al, editors. New York: Springer; 2002. p. 223-40.
22. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
23. Liu Y, Ludes-Meyers J, Zhang Y. et al. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 2002; 21: 7680-9. (Pubitemid 35398814)
24. Kawakami A, Nojima Y, Toyoda A. et al. The zebrafish-secreted matrix protein you/seube2 is implicated in long-range regulation of hedgehog signaling. Curr Biol. 2005; 15: 480-8. (Pubitemid 40323537)
25. Hollway GE, Maule J, Gautier P. et al. Scube2 mediates Hedgehog signalling in the zebrafish embryo. Dev Biol. 2006; 294: 104-18. (Pubitemid 44275143)
26. Woods IG, Talbot WS. The you gene encodes an EGF-CUB protein essential for Hedgehog signaling in zebra-fish. PLoS Biol. 2005; 3: e66.
27. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-94. (Pubitemid 26268864)
28. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ. Controlling cell fate by bone morphogenetic protein receptors. Mol. Cell Endocrinol. 2003; 211: 105-13. (Pubitemid 37491242)
29. Clement JH, Raida M, Sanger J. et al. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J. Oncol 2005; 27: 401-7.
30. Pouliot F, Blais A, Labrie C. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res 2003; 63: 277-81. (Pubitemid 36152479)
31. Benchabane H, Wrana JL. GATA- and Smadl-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol. Cell Biol. 2003; 23: 6646-61. (Pubitemid 37075774)
32. Park YH, Jung HH, Ahn JS, Im YH. Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. Biochem Biophys Res Commun 2008; 377: 389-94.
33. Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 2008; 82: 467-76.
34. Sorlie T, Tibshirani R, Parker J. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 2003; 100: 8418-23. (Pubitemid 36842560)
35. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002; 296: 1646-7. (Pubitemid 34579152)
36. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700. (Pubitemid 36724933)
37. Alarrno EL, Kuukasjarvi T, Karhu R, Kallioniemi A. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 2007; 103: 239-46. (Pubitemid 46789146)
38. Helms MW, Packeisen J, August C. et al. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. J. Pathol 2005; 206: 366-76. (Pubitemid 40903201)
39. Clement JH, Marr N, Meissner A. et al. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J. Cancer Res Clin. Oncol 2000; 126: 271-9. (Pubitemid 30246248)